Occasional nausea and vomiting triggered as a side effect of these medications may also cause a woman to lose a dose without realizing it
This guidance follows the FDAs approval of Wegovy (semaglutide) for an expanded indication to reduce the risk of major cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in adults with established cardiovascular disease (CVD) and who are either obese or overweight
GLP-1 medications slow stomach emptying, so a large, fast, or high-fat drink can sit heavily and trigger nausea or reflux
That 10% difference sounds small until you realize it translates to preserving an extra 1-2 kg of lean tissue over a typical weight loss period
[DOI] [PubMed] [Google Scholar] 111.Mansur SA, Mieczkowska A, Bouvard B, Flatt PR, Chappard D, Irwin N, et al